Part 6: How to Distinguish Authentic Korean Dermal Fillers from Counterfeits

Korean dermal fillers and botulinum toxin have earned a global following on the strength of consistent quality and competitive pricing, and brands like Revolax, Neuramis, and Chaeum are now familiar names in clinics far beyond Korea. That same popularity has created a parallel market for counterfeits, and for a product that goes into a patient's face, the gap between authentic and fake is not a matter of value. It is a matter of safety.

This is Part 6 in our sourcing series, and it is the one closest to what a distributor is actually for. The World Health Organization estimates that roughly one in ten medical products in low and middle income countries is substandard or falsified, a figure that frames just how routine the problem has become across the medicines supply chain.¹ Aesthetic injectables sit squarely inside that risk. The aim here is not to alarm but to equip licensed professionals with a clear, practical method for telling genuine Korean dermal fillers from the fakes that increasingly circulate alongside them.

Why counterfeits exist and the real risks

Counterfeiting follows demand and margin, and high-value injectables offer both. The danger is that a fake filler or toxin is, by definition, an unknown substance. Regulators are blunt about this. The U.S. FDA warns that medical products purchased from unlicensed sources may be misbranded, adulterated, counterfeit, contaminated, improperly stored or transported, ineffective, or unsafe.² Counterfeit fillers have historically been found to contain non-sterile or industrial-grade materials rather than the regulated hyaluronic acid a label promises.

The clinical stakes are well documented. For dermal fillers, the FDA identifies the most serious risk as accidental injection into a blood vessel, which can cause skin necrosis, stroke, or blindness, while unapproved silicone injections have been linked to long term infection, scarring, embolism, and permanent disfigurement.³ The toxin side is no less serious. In a 2024 outbreak the FDA and CDC traced harmful reactions in people across multiple states to counterfeit botulinum toxin given by unlicensed or untrained individuals, with a large share of those affected hospitalized and some treated with botulism antitoxin over concerns the toxin had spread beyond the injection site.⁴

How to verify authenticity

Authenticity is established by a chain of checkable details, not a single glance. Start with the security features. Premium Korean brands seal cartons with tamper-evident holographic stickers and increasingly print a QR or DataMatrix code that should resolve to an official manufacturer verification page. A sticker that is missing, broken, or printed flat without a true hologram is a red flag, as is a code that leads to a dead link or a generic site.

Next, match the lot number and expiration date. Every legitimate carton carries a specific lot number and expiry, and the figures on the syringe or vial must match the printing on the box exactly. The 2024 counterfeit Botox case is instructive on how revealing these markings are: the FDA flagged the fakes by lot number C3709C3, by an active ingredient printed as "Botulinum Toxin Type A" instead of the genuine "OnabotulinumtoxinA," by a 150 unit dose that AbbVie and Allergan do not make, and by carton text that was not in English.⁵ When a lot number is in doubt, the manufacturer can confirm it directly, and AbbVie and Allergan publish a dedicated line for exactly that purpose.⁶

Then read the regulatory marks. In Korea, dermal fillers are regulated as high risk medical devices under the Medical Device Act, typically Class III or IV, and lawful products require MFDS approval, KGMP manufacturing certification, and a designated Korea license holder.⁷ Korea also runs a nationwide serialization system through MFDS, in which prescription products carry a GS1 DataMatrix code encoding the product identifier, serial number, lot, and expiry, with supply chain movements reported to the central platform.⁸ Genuine packaging reflects this regulatory reality. Finally, inspect the print itself: counterfeiters frequently betray themselves with spelling errors, awkward phrasing, broken or incorrect Korean characters, and colors that look faded or pixelated against the sharp printing of authentic cartons.

The role of the supply chain and cold chain

A product can be entirely genuine and still arrive compromised, which is why provenance and handling sit right next to packaging in any honest assessment. Botulinum toxin is a temperature sensitive protein, and manufacturers specify cold chain storage and transport at 2 to 8 degrees Celsius to preserve it.⁹ Heat exposure, light, and mishandling in transit can degrade a neurotoxin, and an item that has broken its cold chain somewhere between factory and clinic is functionally different from the one described on its label, even if the box is real.

This is also why importation route matters as much as the product. The FDA notes that a drug approved in one market becomes unapproved when it is illegally imported, because there is then no oversight of how it was stored, transported, or handled along the way.² An unbroken, documented supply chain is therefore part of what authenticity means in practice, not an optional extra on top of it.

Red flags of unauthorized sources

Most counterfeit exposure traces back to the seller rather than the science, so the source deserves as much scrutiny as the syringe. Price is the clearest early signal. Genuine product has a floor below which it cannot realistically be sold, and a wholesale offer dramatically under the market rate often means counterfeit goods, expired or near-expiry stock, or product that was stored improperly. The pattern regulators keep describing is the same one to avoid: purchases from unlicensed sources, anonymous social media sellers who cannot provide business verification, and websites selling injectables directly to the public.

That last channel is now an active enforcement target. In late 2025 the FDA issued warnings to eighteen websites for illegally marketing unapproved botulinum toxin to U.S. buyers, and notably many of those sites featured Korean aesthetic products, a reminder that a Korean brand name on a webpage is no guarantee of an authorized seller behind it.¹⁰ The FDA's standing guidance is direct: do not buy dermal fillers sold directly to the public, because they may be fake, contaminated, or not approved for use, and unapproved versions of well known fillers have circulated through online retailers.¹¹

Where the supply side fits

This is the part a distributor can genuinely stand behind. We do not promise what any injectable will do for a patient, because that is a clinical judgment for the treating professional. What it does is source genuine products through official channels and keep that provenance traceable, which is the variable that decides whether the item in a clinician's hand is the same one the manufacturer released. Practically, that means authentic Korean product, cold chain handling for temperature sensitive toxins, and compliant shipping to the United States and EU for licensed professionals.

For readers mapping the authentic Korean range, steady official-channel staples include REVOLAX (SUB-Q / DEEP / FINE) and CHAEUM PREMIUM (No.1 to No.4) among the hyaluronic acid fillers, with NEURAMIS in the same family, alongside toxins such as BOTULAX 100 Units. The full filler range sits under Derma Fillers, and the wider catalog under our best selling collection, all intended for use by trained professionals.

Frequently asked questions

Disclaimer. This article is general information for educational purposes and is not medical advice. It describes how to assess product authenticity and sourcing, not what any product will do for an individual, and it makes no efficacy or treatment guarantees. The injectable products referenced are intended for use by trained and licensed professionals. Regulatory requirements and approvals vary by country and change over time; confirm current rules and product approvals with the relevant authority in your market.